Rating History for Prime Medicine (PRME) by BMO Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | David Lebowitz | New Coverage | Outperform (N/A) |
9.00 (N/A) |
3.17 (3.57) |
12.62% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | David Lebowitz | New Coverage | Outperform (N/A) |
9.00 (N/A) |
3.17 (3.57) |
12.62% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||